These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22312021)

  • 1. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
    Flynn C; Zheng S; Yan L; Hedges L; Womack B; Fessel J; Cogan J; Austin E; Loyd J; West J; Zhao Z; Hamid R
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):20-7. PubMed ID: 22312021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.
    Frump AL; Lowery JW; Hamid R; Austin ED; de Caestecker M
    PLoS One; 2013; 8(11):e80319. PubMed ID: 24224048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele.
    Hamid R; Cogan JD; Hedges LK; Austin E; Phillips JA; Newman JH; Loyd JE
    Hum Mutat; 2009 Apr; 30(4):649-54. PubMed ID: 19206171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
    Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
    Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and the molecular pathogenesis of pulmonary arterial hypertension.
    Liu D; Morrell NW
    Curr Hypertens Rep; 2013 Dec; 15(6):632-7. PubMed ID: 24078385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.
    Talati M; West J; Blackwell TR; Loyd JE; Meyrick B
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L363-73. PubMed ID: 20562228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension.
    Phillips JA; Poling JS; Phillips CA; Stanton KC; Austin ED; Cogan JD; Wheeler L; Yu C; Newman JH; Dietz HC; Loyd JE
    Genet Med; 2008 May; 10(5):359-65. PubMed ID: 18496036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
    Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
    J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension.
    Johnson JA; Hemnes AR; Perrien DS; Schuster M; Robinson LJ; Gladson S; Loibner H; Bai S; Blackwell TR; Tada Y; Harral JW; Talati M; Lane KB; Fagan KA; West J
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L474-84. PubMed ID: 22180660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and genomics of pulmonary arterial hypertension.
    Machado RD; Eickelberg O; Elliott CG; Geraci MW; Hanaoka M; Loyd JE; Newman JH; Phillips JA; Soubrier F; Trembath RC; Chung WK
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S32-S42. PubMed ID: 19555857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
    Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years.
    Hinderhofer K; Fischer C; Pfarr N; Szamalek-Hoegel J; Lichtblau M; Nagel C; Egenlauf B; Ehlken N; Grünig E
    PLoS One; 2014; 9(3):e91374. PubMed ID: 24621962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance.
    Cogan J; Austin E; Hedges L; Womack B; West J; Loyd J; Hamid R
    Circulation; 2012 Oct; 126(15):1907-16. PubMed ID: 22923426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
    Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
    Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic and molecular consequences of endothelial Bmpr2 mutation.
    Majka S; Hagen M; Blackwell T; Harral J; Johnson JA; Gendron R; Paradis H; Crona D; Loyd JE; Nozik-Grayck E; Stenmark KR; West J
    Respir Res; 2011 Jun; 12(1):84. PubMed ID: 21696628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
    Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.